Small biotech names continue to sell off in what has been an absolutely miserable year for the sector since mid-FebruaryAt least these names have a lot of company in their latest leg of a long decline as they are joined by most of the rest of market in what only can be described as a stealth bear marketAs James "RevShark" DePorre noted the other d...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.